Found: 14
Select item for more details and to access through your institution.
A Phase 1 Randomized, Double‐Blind, Placebo‐Controlled Trial to Assess the Safety, Tolerability, and Pharmacokinetics of a Respiratory Syncytial Virus Neutralizing Monoclonal Antibody MK‐1654 in Healthy Adults.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 5, p. 556, doi. 10.1002/cpdd.883
- By:
- Publication type:
- Article
Identification and Quantification of a Pneumococcal Cell Wall Polysaccharide by Antibody-Enhanced Chromatography Assay.
- Published in:
- Vaccines, 2024, v. 12, n. 5, p. 469, doi. 10.3390/vaccines12050469
- By:
- Publication type:
- Article
Profiling of hMPV F-specific antibodies isolated from human memory B cells.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-30205-x
- By:
- Publication type:
- Article
Human monoclonal antibodies isolated from a primary pneumococcal conjugate Vaccinee demonstrates the expansion of an antigen-driven Hypermutated memory B cell response.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Genetic ablation or pharmacological blockade of dipeptidyl peptidase IV does not impact T cell-dependent immune responses.
- Published in:
- BMC Immunology, 2009, v. 10, p. 1, doi. 10.1186/1471-2172-10-19
- By:
- Publication type:
- Article
Neutralization Activity of Anti-drug Antibodies Against a Biotherapeutic Can Be Predicted from a Comprehensive Pharmacokinetics, Pharmacodynamics, and Anti-drug Antibody Data Analysis.
- Published in:
- AAPS Journal, 2022, v. 24, n. 6, p. 1, doi. 10.1208/s12248-022-00753-7
- By:
- Publication type:
- Article
Potent neutralizing antibodies elicited by dengue vaccine in rhesus macaque target diverse epitopes.
- Published in:
- PLoS Pathogens, 2019, v. 15, n. 6, p. 1, doi. 10.1371/journal.ppat.1007716
- By:
- Publication type:
- Article
The roles of antibody variable region hypermutation and selection in the development of the memory B-cell compartment.
- Published in:
- Immunological Reviews, 1998, v. 162, n. 1, p. 183, doi. 10.1111/j.1600-065X.1998.tb01441.x
- By:
- Publication type:
- Article
Development and Characterization of Monoclonal Antibodies to Staphylococcus aureus Capsule Type 5.
- Published in:
- FASEB Journal, 2008, v. 22, p. 669, doi. 10.1096/fasebj.22.2_supplement.669
- By:
- Publication type:
- Article
Discovery and Characterization of Phage Display-Derived Human Monoclonal Antibodies against RSV F Glycoprotein.
- Published in:
- PLoS ONE, 2016, v. 11, n. 6, p. 1, doi. 10.1371/journal.pone.0156798
- By:
- Publication type:
- Article
Modified mRNA/lipid nanoparticle-based vaccines expressing respiratory syncytial virus F protein variants are immunogenic and protective in rodent models of RSV infection.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. 1, doi. 10.1038/s41541-020-0163-z
- By:
- Publication type:
- Article
Functional Evaluation and Genetic Evolution of Human T-Cell Responses After Vaccination With a Conditionally Replication-Defective Cytomegalovirus Vaccine.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Effector and central memory poly-functional CD4<sup>+</sup> and CD8<sup>+</sup> T cells are boosted upon ZOSTAVAX® vaccination.
- Published in:
- Frontiers in Immunology, 2015, v. 6, p. 1, doi. 10.3389/fimmu.2015.00553
- By:
- Publication type:
- Article
Respiratory syncytial virus elicits enriched CD8<sup>+</sup> T lymphocyte responses in lung compared with blood in African green monkeys.
- Published in:
- PLoS ONE, 2017, v. 12, n. 11, p. 1, doi. 10.1371/journal.pone.0187642
- By:
- Publication type:
- Article